Gosling Plague Vaccine, Live

Live Gosling Plague Vaccine

Gosling Plague Vaccine, Live (Strain GD), prevents gosling plague in geese before laying, providing immunity to offspring for 21-270 days post-vaccination. Administer 1.0ml intramuscularly 20-30 days before laying.

  • Vaccine Type: Live Attenuated Vaccine
  • Target Species: Geese (breeding stock)
  • Indication / Application: Prevention of Gosling Plague
  • Manufacturing: Produced in GMP-certified facility
  • Supply Mode: Bulk Supply / Distributor / OEM Available
  • Origin: China

Goose Parvovirus Vaccine Description

This live attenuated vaccine is developed using a duck-embryo-adapted gosling plague virus strain (GD), providing effective protection against gosling plague (goose parvovirus infection), a highly contagious and often fatal disease affecting young goslings.

Gosling plague is characterized by high mortality, severe enteritis, and growth retardation, causing significant economic losses in goose production systems. Control of this disease relies heavily on maternal antibody transfer from vaccinated breeding geese to their offspring.

This vaccine is specifically designed for pre-laying immunization of breeding geese, enabling the production of high levels of maternal antibodies. As a result, goslings hatched from vaccinated geese between 21 and 270 days post-vaccination receive effective passive immunity against the disease.

The vaccine demonstrates strong immunogenicity and is suitable for integration into breeder flock vaccination programs to ensure consistent protection of young birds during their most vulnerable stage.

Immunization Program

  • Breeding Geese:
    • Vaccinate 20–30 days before laying
  • Maternal Immunity:
    • Offspring protected from 21 to 270 days post-vaccination

Dosage & Administration

  • Route: Intramuscular injection
  • Dosage:
    • 1.0 mL per bird (1 dose)
  • Dilute with sterile normal saline according to label instructions
  • Use immediately after reconstitution

Composition

  • Attenuated gosling plague virus (strain GD): ≥ 10³.⁰ ELD50 per dose

Product Characteristics

  • Appearance: Sponge-like loose mass
  • Easily detaches from vial wall
  • Rapid dissolution after dilution

Safety & Precautions

  • Do NOT vaccinate goslings directly
  • Use only in breeding geese
  • After dilution:
    • Store in cool, dark conditions
    • Use within 4 hours
  • Maintain aseptic injection procedures
  • Disinfect injection site before administration
  • Dispose of:
    • Vaccine vials
    • Equipment
    • Residual vaccine according to biosafety protocols

Packaging & Specification

  • Specifications:
    • 1000 doses/vial
    • 2000 doses/vial
  • Packaging: 10 vials/box

Storage & Shelf Life

  • Storage: 2–8°C
  • Protect from light
  • Shelf Life: 24 months

Contact us today to become a partner!

Inquire Now

Relate News

Get a free quote

Tell us what you need and we will get back to you within eight hours!

CONTACT US

Become our partner